Preclinical studies on intestinal administration of antisense oligonucleotides as a model for oral delivery for treatment of duchenne muscular dystrophy.

van Putten, Maaike; Young, Courtney; van den Berg, Sjoerd; Pronk, Amanda; Hulsker, Margriet; Karnaoukh, Tatyana G; Vermue, Rick; van Dijk, Ko Willems; de Kimpe, Sjef; Aartsma-Rus, Annemieke

van Putten, Maaike; Young, Courtney; van den Berg, Sjoerd; Pronk, Amanda; Hulsker, Margriet; Karnaoukh, Tatyana G; Vermue, Rick; van Dijk, Ko Willems; de Kimpe, Sjef; Aartsma-Rus, Annemieke.

Afiliación

van Putten M; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Young C; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
van den Berg S; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Pronk A; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Hulsker M; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Karnaoukh TG; Prosensa Therapeutics BV, Leiden, the Netherlands.
Vermue R; Prosensa Therapeutics BV, Leiden, the Netherlands.
van Dijk KW; 1] Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands [2] Department of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands.
de Kimpe S; Prosensa Therapeutics BV, Leiden, the Netherlands.
Aartsma-Rus A; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.

Mol Ther Nucleic Acids ; 3: e211, 2014 Nov 18.

Article en En | MEDLINE | ID: mdl-25405468

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google